Novartis Call for Pre-Proposals
Our objective is to work together with academic institutions to de-risk innovation and bridge the translational gap of early-stage research. We would like to collaborate and form long term relationships with academic scholars who are deeply committed to translating their scientific discoveries into patients. We offer academic institutions new opportunities for scientific engagement with Novartis through in-licensing of academic technologies, research collaborations and opportunities for co-creation with our scientists, and long-term strategic partnerships. We are committed to working together with academic scholars to translate the next great innovative ideas into powerful medicines to change the future of medicine.
Please find detailed information and the Pre-Proposal Submission Template attached. There should be NO confidential information disclosed in the pre-proposals.
Amount of funding: The budget amount is expected to be $100,000 to $300,000 for one year (including indirect costs). Novartis will rely on what the faculty, in collaboration with RMG, estimate as appropriate; however, details on budget would not be explored unless a pre-proposal is selected for a full proposal submission.
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver). CE applicants must obtain an approved CE faculty PI waiver BEFORE the pre-proposal deadline.
Instructions for CE faculty PI waiver requests: Submit the required, completed CE faculty PI waiver template and attachments directly to Kathleen Thompson at klt@stanford.edu by end of day on July 29, 2024. Please do not contact your RPM/RMG or CGO/OSR regarding waivers for this program.
Areas of Interest:
- Cardiovascular & metabolic
- Oncology
- Immunology
- Neuroscience
- Renal diseases
- Diseases of aging and regenerative medicines
- Gene therapies
- xRNA
- Please see the PDF attachments for specific thematic Novartis priorities under each area.
Timeline:
July 29, 2024 – CE faculty PI waiver requests due (if applicable)
August 1, 2024 – Pre-proposal submission deadline to Stanford Medicine - Industry Relations (SM-IR) team
August 12, 2024 – Submission of completed pre-proposals to Novartis by SM-IR
Deadlines for full proposal submission will be announced at a later time to selected faculty. This timeline will include the institutional representative (RPM/RMG or CGO/OSR) review deadline and Proposal Intake Form (PIF) requirement.
Submission Instructions for Pre-proposals:
Fill out the attached pre-proposal template. Email the complete pre-proposal to Nour Malek at nrmalek@stanford.edu and Nicole Kay at nkay@stanford.edu before August 1, 2024. The Industry Relations team will review the submissions with the Office Technological Licensing (OTL) and Industry Contracting Office (ICO) and then formally submit all pre-proposals to Novartis on behalf of Stanford.
There should be NO confidential information disclosed in the pre-proposals.
Institutional representative: you do not need to submit your pre-proposals through RMG or OSR for institutional approval; you may submit your pre-proposal directly to Nour Malek and Nicole Kay per the instructions above. If invited to submit a full proposal, please initiate your Proposal Intake Form (PIF) at your earliest convenience. Final proposal submission will require institutional approval prior to submission. Any CE faculty PI waiver requests should be submitted directly to Kathleen Thompson per the instructions above.
Questions? Please contact Nour Malek at nrmalek@stanford.edu and Nicole Kay at nkay@stanford.edu
Stanford Resources
Funding Information for the Stanford community
Limited submission programs, NIH resources, DoD CDMRP, internal funding opportunities, searchable funding databases.
Institutional representatives and Internal Proposal Deadline Policy
School of Medicine PIs:
RPM Department Assignments and SoM internal proposal deadline policy
A Proposal Intake Form (PIF) in SeRA is required for all sponsored project proposal submissions in the School of Medicine (except for fellowships, clinical trials, and Internal Seed Funding NOT from sponsored projects).
PIs in all Other Schools:
Office of Sponsored Research (OSR) Contract and Grant Officer Pre-Award & Post-award department assignments
The budget is expected to include indirect costs. Novartis will rely on what the faculty, in collaboration with RMG, estimate as appropriate; however, details on budget would not be explored unless a pre-proposal is selected for a full proposal submission.
